Abstract
Alzheimer’s disease (AD) is the commonest form of dementia, affecting about 5% of the population over 65 years of age and 20% of those aged 80 years. With the increasing number and proportion of elderly people, AD has become one of the major diseases in terms of prevalence, morbidity, mortality, and financial implications. As a consequence, investigation into its pathogenesis has become a health priority, since it is only in this way that effective symptomatic and curative therapies are likely to be developed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abe K, St George-Hyslop PH, Tanzi RE, Kogure K (1991) Induction of amyloid precursor protein mRNA after heat shock in cultured human lymphoblastoid cells. Neurosci Lett 125: 169–71
Barton AJL, Harrison PJ, Najlerahim A, Heffernan J, McDonald B, Robinson JR, Davies DC, Harrison WJ, Mitra P, Hardy JA, Pearson RCA (1990) Increased tau messenger RNA in Alzheimer’s disease hippocampus. Am J Pathol 137: 497–502
Boyes BE, Walker DG, McGeer PL, McGeer EG (1992) Identification and characterization of a large human brain gene whose expression is increased in Alzheimer disease. Mol Brain Res 12: 47–57
Caporaso GL, Gandy SE, Buxbaum JD, Ramabhadran TV, Greengard P (1992) Protein phosphorylation regulates secretion of Alzheimer β/A4 amyloid precursor protein. Proc Natl Acad Sci USA 89: 3055–3059
Cohen ML, Golde TE, Usiak ME, Younkin LH, Younkin SG (1988) In situ hybridization of nucleus basalis neurons shows increased beta-amyloid MRNA in Alzheimer’s disease. Proc Natl Acad Sci USA 85: 1227–1231
Denman R, Potempska A, Wolfe G, Ramakrishna N, Miller DL (1991) Distribution and activity of alternatively spliced Alzheimer amyloid peptide precursor and scrapie PrP mRNAs on rat brain polysomes. Arch Biochem Biophys 288: 29–38
de Sauvage F, Octave J-N (1989) A novel mRNA of the A4 amyloid precursor gene coding for a possibly secreted protein. Science 245: 651–653
de Sauvage F, Kruys V, Maririx O, Huez G, Octave J-N (1992) Alternative polyadenylation of the amyloid protein precursor mRNA regulates translation. EMBO J 11: 3099–3103
Doebler JA, Rhoads RE, Anthony A, Markersbery WT (1989) Neuronal RNA in Pick’s and Alzheimer’s diseases: comparison of disease-susceptible and disease-resistant areas. Arch Neurol 46: 134–137
Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D, Ward PJ (1990) Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248: 1122–1124
Ginty DD, Bading H, Greenberg ME (1992) Trans-synaptic regulation of gene expression. Curr Opinion Neurobiol 2: 312–316
Glenner GG, Wong CW (1984) Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885–890
Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fldani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349: 704–706
Golde TE, Estus S, Usiak M, Younkin LH, Younkin SG (1990) Expression of β amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer’s disease using PCR. Neuron 4: 253–267
Golde TE, Estus S, Younkin LH, Selkoe DJ, Younkin SG (1992) Processing of the amyloid protein precursor to potentially amy- loidogenic derivatives. Science 255: 728–730
Goldgaber D, Harris HW, Hla T, Maciag T, Donnelly RJ, Jacobsen JS, Vitek MP, Gajdusek DC (1989) Interleukin 1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA 86: 7606–7610
Griffin WST, Ling C, White CL III, Morrison-Bogorad M (1990) Polyadenylated messenger RNA in paired helical filament-immunoreactive neurons in Alzheimer disease. Alzheimer Dis Assoc Disord 4: 69–78
Haan J, Hardy JA, Roos RAC (1991) Hereditary cerebral hemorrhage with amyloidosis - Dutch type: its importance for Alzheimer research. Trends Neurosci 14: 231–234
Hardy JA (1992) An ‘anatomical cascade’ hypothesis for Alzheimer’s disease. Trends Neurosci 15: 200–201
Hardy JA, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends Pharmacol Sci 12: 383–388
Harrison PJ, Mullan MJ (1991) Alzheimer’s disease: the significance of a P amyloid precursor protein gene mutation. Curr Opinion Neurol Neurosurg 4: 908–913
Harrison PJ, Pearson RCA (1990) In situ hybridization histochemistry and the study of gene expression in the human brain. Prog Neurobiol 34: 271–312
Harrison PJ, Pearson RCA (1993) Principles and practice of in situ hybridization histochemistry in neuropsychiatric research. In: Roberts GW, Polak JM (eds) Molecular neuropathology. Cambridge University Press, Cambridge (in press)
Harrison PJ, Barton AJL, Pearson RCA (1991) Expression of amyloid beta-protein mRNAs in familial Alzheimer’s disease. NeuroReport 2: 152–154
Harrison PJ, Barton AJL, Najlerahim A, McDonald B, Pearson RCA (1991) Regional and neuronal reductions of polyadenylated messenger RNA in Alzheimer’s disease. Psychol Med 21: 855–866
Harrison PJ, Procter AW, Exworthy T, Roberts GW, Najlerahim A, Barton AJL, Pearson RCA (1993) Expression of heat shock protein (hsx70) mRNA in human brain: effects of neurodegenerative disease and agonal state. Neuropathol Appl Neurobiol (in press)
Jacobsen JS, Blume AJ, Vitek MP (1991) Quantitative measurement of alternatively spliced amyloid precursor protein mRNA expression in Alzheimer’s disease and normal brain by SI nuclease protection analysis. Neurobiol Aging 12: 585–592
Jacobsen JS, Muenkel HA, Blume AJ, Vitek MP (1991) A novel species-specific RNA related to alternatively spliced amyloid precursor protein mRNAs. Neurobiol Aging 12: 575–583
Johnson SA, Rogers J, Finch CE (1989) APP-695 transcript prevalence is selectively reduced during Alzheimer’s disease in cortex and hippocampus but not in cerebellum. Neurobiol Aging 10: 267–272
Johnson SA, McNeill T, Cordell B, Finch CE (1990) Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer’s disease. Science 248: 854–857
Kang J, Lemaire H-G, Unterbeck A, Salbaum J, Masters CL, Grzeschik K-H, Multhaup G, Beyreuther K, Muller-Hill B (1987) The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell surface receptor. Nature 325: 733–736
Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H (1988) Novel precursor of Alzheimer’s disease amyloid protein shows pro tease inhibitor activity. Nature 331: 530–532
Konig G, Salbaum JM, Wiestler O, Lang W, Schmitt HP, Masters CL, Beyreuther K (1991) Alternative splicing of the βA4 amyloid gene of Alzheimer’s disease patients in cortex of control and Alzheimer’s disease patients. Mol Brain Res 9: 259–262
Koo EH, Sisodia SS, Cork LC, Unterbeck A, Bayney RM, Price DL (1990) Differential expression of amyloid precursor protein mRNAs in cases of Alzheimer’s disease and in aged nonhuman primates. Neuron 2: 97–104
Koo EH, Sisodia SS, Archer DR (1990) Precursor of amyloid pro tein in Alzheimer disease undergoes fast axonal transport. Proc Natl Acad Sci USA 87: 1561–1565
Kosik KS (1992) Alzheimer’s disease: a cell biological perspective. Science 56: 780–783
Langstrom NS, Anderson JP, Lindroos HG, Winblad B, Wallace WC (1989) Alzheimer’s disease-associated reduction of polysomal mRNA translation. Mol Brain Res 5: 259–269
Lewis DA, Higgins GA, Young WG, Goldgaber D, Gajdusek DC, Wilson MC, Morrison JH (1988) Distribution of precursor amyloid β-protein messenger RNA in human cerebral cortex: relationship to neurofibrillary tangles and neuritic plaques. Proc Natl Acad Sci USA 85: 1691–1695
Maschoff K, White CL III, Jennings LW, Morrison-Bogorad MR (1989) Ribonuclease activities and distribution in Alzheimer’s and control brains. J Neurochem 52: 1071–1078
Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12: 376–389
Nakamura Y, Takeda M, Niigawa H, Hariguchi S, Nishimura T (1992) Amyloid β-protein precursor deposition in rat hippocampus lesioned by ibotenic acid injection. Neurosci Lett 136: 95–98
Neve RL, Finch EA, Dawes LR (1988) Expression of the Alzheimer amyloid precursor gene transcripts in the human brain. Neuron 1: 669–677
Neve RL, Rogers J, Higgins GA (1990) The Alzheimer amyloid precursor-related transcript lacking the β/A4 sequence is specifically increased in Alzheimer’s disease brain. Neuron 5: 329–338
Oyama F, Shimada H, Oyama R, Titani K, Ihara Y (1991) Differential expression of B amyloid protein precursor (APP) and tau mRNA in the aged human brain: individual variability and correlation between APP-751 and four-repeat tau. J Neuropathol Exp Neurol 50: 560–578
Palmert MR, Golde TE, Cohen ML, Kovacs DM, Tanzi RE, Gusella JF, Usiak MF, Younkin LH, Younkin SG (1988) Amyloid protein precursor messenger RNAs: differential expression in Alzheimer’s disease. Science 241: 1080–1084
Pearson RCA, Powell TPS (1989) The neuroanatomy of Alzheimer’s disease. Rev Neurosci 2: 101–122
Pearson RCA, Barton AJL, Heath PR, Harrison PJ (1992) Changes in messenger RNA in dementia. In: Hunter AJ, Clark M (eds) Neurodegeneration. Academic Press, London, pp 151–166
Quon D, Wang Y, Catalano R, Scardina JM, Murakami K, Cordell B (1991) Formation of β-amyloid protein deposits in brains of transgenic mice. Nature 352: 239–241
Roberts GW, Gentleman SM, Lynch A, Graham DI (1991) βA4 amyloid protein deposition in brain after head trauma. Lancet 338: 1422–1423
Royston MC, Rothwell NJ, Roberts GW (1992) Alzheimer’s disease: pathology to potential treatments. Trends Pharmacol Sci 13: 131–133
St George Hyslop PH, Haines JL, Farrer LA, Polinsky R, Van Broeckhoven C, Goate A, Crapper McLachlan DR, Orr H, Bruni AC, Sorbi S, Rainero I, Foncin J-F, Pollen D, Cantu J-M, Tupler R, Voskresenskaya N, Mayeux R, Growdon J, Fried VA, Myers RH, Nee L, Backhovens H, Martin J-J, Rossor M, Owen MJ, Mullan M, Percy ME, Karlinsky H, Rich S, Heston L, Montesi M, Mortilla M, Nacmias N, Gusella JF, Hardy JA and other members of the FAD Collaborative Study Group (1990) Genetic linkage studies suggest that Alzheimer’s disease is not a single homogeneous disorder. Nature 347: 194–197
Sajdel-Sulkowska EM, Marotte CA (1984) Alzheimer’s disease brain: alteration in RNA levels and in a ribonuclease-inhibitor complex. Science 225: 947–949
Salbaum JM, Weidemann A, Lemaire H-G, Masters CL, Beyreuther K (1988) The promoter of Alzheimer’s disease amyloid A4 precursor gene. EMBO J 7: 2807–2813
Scott JN, Parhad IM, Clark AW (1991) β-amyloid precursor protein gene is differentially expressed in axotomised sensory and motor systems. Mol Brain Res 10: 315–325
Selkoe DJ (1991) The molecular pathology of Alzheimer’s disease. Neuron 6: 487–498
Siman R, Card JP, Nelson RB, Davis LG (1989) Expression of β- amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron 3: 275–285
Sisodia SS (1992) β-Amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci USA 89:6075–6079
Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL (1990) Evidence that β-amyloid protein in Alzheimer’s disease is not de rived by normal processing. Science 248: 492–495
Tanaka S, Nakamura S, Ueda K, Kameyama M, Shiojiri S, Takahashi Y, Kitasguchi N, ito H (1988) Three types of amyloid protein precursor mRNA in human brain: their differential expression in Alzheimer’s disease. Biochem Biophys Res Commun 157: 472–479
Tanaka S, Shiojiri S, Takahashi Y, Kitaguchi N, Ito H, Kameyama M, Kimura J, Nakamura S, Ueda K (1989) Tissue-specific expres sion of three types of β-protein precursor mRNA: enhancement of protease inhibitor-harboring types in Alzheimer’s disease brain. Biochem Biophys Res Commun 165: 1406–1414
Tanzi RE, McClatchey Al, Lamperti ED, Villa-Komaroff L, Gusel la JF, Neve RL (1 988) Protease inhibitor domain encoded by an amyloid protein precursor MRNA associated with Alzheimer’s dis ease. Nature 331: 528–530
Tanzi RE, St George-Hyslop Ai, Gusella JF (1989) Molecular genetic approaches to Alzheimer’s disease. Trends Neurosci 12: 152–158
Tanzi RE, Hyman B (1991) Alzheimer’s mutation. Nature 350: 564
van Nostrand WE, Farrow JS, Wagner SL, Bhasin R, Goldgaber D, Cotrnan CW, Cunningham DD (1991) The predominant form of the amyloid β-protein precursor in human brain is protease nexin 2. Proc Natl Acad Sci USA 88: 10302–10306
Wallace WC, Bragin V, Robakis NK, Sambamurti K, VanderPutten D, Merril CR, Davis KL, Santucci AC, Haroutunian V (1991) In creased biosynthesis of Alzheimer amyloid precursor protein in the cerebral cortex of rats with lesions of the nucleus basalis of Meynert. Mol Brain Res 10: 173–178
Yoshikai S, Sasaki H, Dohura K, Furuya H, Sakaki Y (1990) Genomic organisation of the human amyloid beta-protein precursor gene. Gene 87: 257–263
Zubenko GS, Farr J, Stiffler JS, Hughes HB, Kaplan BB (1992) Clinically-silent mutation in the putative iron-responsive element in exon 17 of the B-amyloid precursor protein gene. J Neuropathol Exp Neurol 51: 459–463
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Harrison, P.J. (1994). Expression of the β-Amyloid Precursor Protein Gene and the Pathogenesis of Alzheimer’s Disease. In: Harrison, P.J. (eds) Regulation of Gene Expression and Brain Function. Basic and Clinical Aspects of Neuroscience, vol 6. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78458-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-78458-3_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-57156-8
Online ISBN: 978-3-642-78458-3
eBook Packages: Springer Book Archive